Finance Minister Nirmala Sitharaman announces Biopharma Shakti, a ₹10,000 crore plan to boost biologics, biosimilars, clinical trials and regulatory capacity in India.
The US will no longer participate in the WHO’s global influenza monitoring system – a shift experts say will lead to more flu ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results